MEDICINE IN THE FUTURE WILL NOT NEED CELLS Trademark

Trademark Overview


On Wednesday, September 20, 2023, a trademark application was filed for MEDICINE IN THE FUTURE WILL NOT NEED CELLS with the United States Patent and Trademark Office. The USPTO has given the MEDICINE IN THE FUTURE WILL NOT NEED CELLS trademark a serial number of 98188567. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, October 21, 2024. This trademark is owned by MAM HOLDINGS OF WEST FLORIDA, L.L.C.. The MEDICINE IN THE FUTURE WILL NOT NEED CELLS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Advertising, Business and Retail Services, Construction & Repair Services, and Computer & Software Services & Scientific Services categories with the following description:

Providing technical information in the field of manufacturing biomaterials, pharmaceuticals, regenerative medicine products, and biologics, and their manufacturing; biomanufacturing for others in the nature of processing of medical materials, namely, custom fabrication, and assembly of biologics for research, development, and medical purposes, using biological materials in the manufacturing process; biologic manufacturing for others, namely, isolating and processing biologic tissue products using human placental and birth tissues in the manufacturing process for use in regenerative medicine; custom biologic manufacturing for others, namely, isolating and processing biologic products from human placental and birth tissues for use in regenerative medicine; custom manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics for others; biomanufacturing for others, namely, manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and b...

Pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders, and sports related injuries; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the prevention and treatment of cancer, and suppressing tumors; pharmaceutical products for regenerative medicine, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hemat...

sterilizing of human amniotic fluid

Wholesale ordering services, online retail ordering services, retail store ordering services, and catalog ordering services featuring medical biomaterials, pharmaceutical drugs, pharmaceutical preparations, and regenerative medicines; distributorship services in the field of medical biomaterials, pharmaceutical drugs, pharmaceutical preparations, and regenerative medicines; wholesale services by direct solicitation by sales agents in the field of pharmaceutical, regenerative medicine products, and biologics; publicity and sales promotion relating to goods and services; on-line wholesale and retail store services featuring pharmaceutical, regenerative medicine products, and biologics, also accessible by telephone, facsimile, and mail order; and wholesale store services for pharmaceutical preparations and medical supplies

Development of biomedical and pharmaceutical products, preparations and medicines; pharmaceutical and biomedical product evaluation; research and development services in the field of medical preparations, biologics, and regenerative medicine and consultancy services relating thereto; scientific investigations for medical purposes; laboratory research in the field of regenerative medicine, biomedical products, and pharmaceuticals; medical research laboratory services and scientific laboratory services; biomedical research services; biotechnology research; chemical research; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; drug discovery services; industrial research in the field of regenerative and reparative medical therapies; medical research; pharmaceutical drug development services; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clin...

General Information


Serial Number98188567
Word MarkMEDICINE IN THE FUTURE WILL NOT NEED CELLS
Filing DateWednesday, September 20, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding technical information in the field of manufacturing biomaterials, pharmaceuticals, regenerative medicine products, and biologics, and their manufacturing; biomanufacturing for others in the nature of processing of medical materials, namely, custom fabrication, and assembly of biologics for research, development, and medical purposes, using biological materials in the manufacturing process; biologic manufacturing for others, namely, isolating and processing biologic tissue products using human placental and birth tissues in the manufacturing process for use in regenerative medicine; custom biologic manufacturing for others, namely, isolating and processing biologic products from human placental and birth tissues for use in regenerative medicine; custom manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics for others; biomanufacturing for others, namely, manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics, pharmaceuticals, regenerative medicine products, and biologics using biological materials in the manufacturing process; technical consulting related to the manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics; treatment of materials for the manufacture of biomaterials, pharmaceuticals, regenerative medicine products, and biologics, by means of cryogenic processing; biomanufacturing for others in the nature of processing of biomaterials for use in manufacture of pharmaceuticals, regenerative medicine products, and biologics; cryogenic preservation services of biologics; processing of medical materials, namely, custom fabrication, and assembly of biologics for therapeutic purposes using biological materials in the manufacturing process; and biologic manufacturing for others, namely, isolating and processing biologic tissue products using human placental and biologic birth tissues for use in regenerative medicine
Goods and ServicesPharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders, and sports related injuries; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the prevention and treatment of cancer, and suppressing tumors; pharmaceutical products for regenerative medicine, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders; biologically derived products developed from perinatal tissue and fluid material for medical and medical regenerative purposes; bioengineered placental biomaterials for medical purposes; biologics, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders; tissue-regenerative medical preparations, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders; therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for use in the treatment of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for the prevention of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; and pharmaceutical preparations, namely, for treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, and ocular disorders and diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, and skin damage and disorders, tissue damage and disorders, soft tissue wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders, and delivery systems therefor sold as a unit, for use in regenerative medicine
Goods and Servicessterilizing of human amniotic fluid
Goods and ServicesWholesale ordering services, online retail ordering services, retail store ordering services, and catalog ordering services featuring medical biomaterials, pharmaceutical drugs, pharmaceutical preparations, and regenerative medicines; distributorship services in the field of medical biomaterials, pharmaceutical drugs, pharmaceutical preparations, and regenerative medicines; wholesale services by direct solicitation by sales agents in the field of pharmaceutical, regenerative medicine products, and biologics; publicity and sales promotion relating to goods and services; on-line wholesale and retail store services featuring pharmaceutical, regenerative medicine products, and biologics, also accessible by telephone, facsimile, and mail order; and wholesale store services for pharmaceutical preparations and medical supplies
Goods and ServicesDevelopment of biomedical and pharmaceutical products, preparations and medicines; pharmaceutical and biomedical product evaluation; research and development services in the field of medical preparations, biologics, and regenerative medicine and consultancy services relating thereto; scientific investigations for medical purposes; laboratory research in the field of regenerative medicine, biomedical products, and pharmaceuticals; medical research laboratory services and scientific laboratory services; biomedical research services; biotechnology research; chemical research; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; drug discovery services; industrial research in the field of regenerative and reparative medical therapies; medical research; pharmaceutical drug development services; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields; scientific research and development; technology research in the field of regenerative and reparative medical therapies; pharmaceutical, medical, and scientific research and development services in the fields of cell therapy, gene therapy, oncology, immunotherapy, and regenerative medicine; scientific research for medical purposes in the area of regenerative medicine, wound repair, surgical repair, and nerve repair and regeneration; providing medical and scientific research information relating to medical treatment in the nature of results of scientific research and clinical data in the areas of regenerative medicine, wound repair, surgical repair, nerve repair and regeneration; clinical research in the areas of regenerative medicine, wound repair, surgical repair, nerve repair and regeneration, and pharmaceutical preparations and delivery systems, to provide information on functional recovery and treatment outcomes; research and development of new products and procedures in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of pharmaceutical preparations and delivery systems therefor, regenerative medicine, wound repair, surgical repair, nerve repair and regeneration, and tissue generation, processing and transplantation; scientific and technological services and research and design relating thereto, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials, and pharmaceutical research and development services; medical and scientific research information in the field of novel pharmaceutical discovery and development; research and development in the field of novel pharmaceutical treatments and clinical trials; providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, October 5, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, October 5, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class037 - Building construction; repair; installation services.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, May 2, 2024
Primary Code037
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 5, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMAM HOLDINGS OF WEST FLORIDA, L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTarpon Springs, FL 34689

Trademark Events


Event DateEvent Description
Saturday, September 23, 2023NEW APPLICATION ENTERED
Thursday, October 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 8, 2024NON-FINAL ACTION WRITTEN
Thursday, February 8, 2024NON-FINAL ACTION E-MAILED
Thursday, February 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 2, 2024ASSIGNED TO EXAMINER
Thursday, May 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 16, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, October 1, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, October 3, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, October 3, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, October 3, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 3, 2024EXAMINER'S AMENDMENT ENTERED
Friday, October 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER